Wed, September 18, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 30, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 27, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 13, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 7, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 30, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 26, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 14, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 12, 2024
[ 12:00 AM ] - WOPRAI
Wed, March 6, 2024
[ 12:00 AM ] - WOPRAI
Tue, February 20, 2024
[ 12:00 AM ] - WOPRAI
Fri, December 29, 2023
[ 12:00 AM ] - WOPRAI
Mon, November 6, 2023
[ 12:00 AM ] - WOPRAI
Fri, September 1, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 15, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 3, 2023
[ 12:00 AM ] - WOPRAI
Mon, July 17, 2023
[ 12:00 AM ] - WOPRAI
Mon, June 12, 2023
[ 12:00 AM ] - WOPRAI
Wed, May 10, 2023
[ 12:00 AM ] - WOPRAI
Wed, April 26, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, March 14, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
Fri, November 11, 2022
[ 12:00 AM ] - WOPRAI
Wed, March 16, 2022
[ 12:00 AM ] - WOPRAI
Mon, March 14, 2022
[ 12:00 AM ] - WOPRAI
Mon, February 7, 2022
[ 12:00 AM ] - WOPRAI
Wed, December 22, 2021
[ 12:00 AM ] - WOPRAI
Tue, August 3, 2021
Sumant Kulkarni Maintained (zvra) at Strong Buy with Decreased Target to $22 on, Sep 18th, 2024
Sumant Kulkarni of Canaccord Genuity, Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Decreased Target from $24 to $22 on, Sep 18th, 2024.
Sumant has made no other calls on ZVRA in the last 4 months.
There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Sumant's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Sumant
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, August 14th, 2024
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Monday, August 5th, 2024
Contributing Sources